Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935314

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935314

Dermatophytic Onychomycosis Treatment Market, By Product Type, By Treatment, By End User, By Geography

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Dermatophytic Onychomycosis Treatment Market is estimated to be valued at USD 7,296.6 Mn in 2026 and is expected to reach USD 12,219.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 7,296.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.60% 2033 Value Projection: USD 12,219.7 Mn

Nail onychomycosis is a fungal infection is caused by a trichophyton rubrum, trichophyton mentagrophytes, and in some cases it is caused by yeasts and molds. The major factors responsible for nail onchomycosis infection is increased exposure to worm and moist environment which leads to perfect condition for fungus to grow and proliferate. The major symptoms of onychomycosis comprises of white and yellow spots under the nail leading to discoloration, nail thickening, and formation of crumbling edges on the nail.

Key features of the study

  • This report provides in-depth analysis of the global dermatophytic onychomycosis treatment market and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global dermatophytic onychomycosis treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Anacor Pharmaceuticals, Inc., NovaQuest Capital Management, L.L.C., and Novan, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global dermatophytic onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatophytic onychomycosis treatment market

Market Segmentation

  • By Product Type
    • Tablets
    • Nail Paints
  • By Treatment
    • Oral
    • Topical
  • By End User
    • Hospitals
    • Clinics
    • Independent Pharmacies
    • Mail Order Pharmacies
    • Drug Stores
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Global Dermatophytic Onychomycosis Treatment Market: Competitive Landscape
    • Valeant Pharmaceuticals International Inc.
    • Galderma S.A.
    • Novartis AG
    • Pfizer Inc.
    • Moberg Pharma AB
    • Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
    • Anacor Pharmaceuticals, Inc.
    • NovaQuest Capital Management, L.L.C.
    • Novan, Inc.
Product Code: CMI2053

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Treatment
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Reimbursement Scenario
  • Merger and Acquisition Scenario
  • PEST Analysis

4. Global Dermatophytic Onychomycosis Treatment Market, By Product Type, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2033 (%)
    • Y-o-Y Growth Analysis, 2017 - 2033
    • Segment Trends
  • Tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Nail Paints
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Dermatophytic Onychomycosis Treatment Market, By Treatment, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2033 (%)
    • Y-o-Y Growth Analysis, 2017 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Dermatophytic Onychomycosis Treatment Market, By End User, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2033 (%)
    • Y-o-Y Growth Analysis, 2017 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Independent Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Mail Order Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Dermatophytic Onychomycosis Treatment Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2033
  • North America
    • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Treatment, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
      • South Africa
      • Central Africa
      • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Valeant Pharmaceuticals International Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Galderma S.A.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Novartis AG
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Moberg Pharma AB
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Anacor Pharmaceuticals, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • NovaQuest Capital Management, L.L.C.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Novan, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
      • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!